https://www.selleckchem.com/pr....oducts/Temsirolimus.
As expected, the cell viability of MDR1-knockout hiPSC-IECs was significantly decreased by vinblastine treatment. Furthermore, teratomas were formed by subcutaneous transplantation of hiPSC-IECs mixed with undifferentiated hiPSCs into mice, but they were not observed when the transplanted cells were pre-treated with vinblastine. Vinblastine-treated hiPSC-IECs would be an effective cell source for safe regenerative medicine.We conducted two lines of genome-editing experiments of mouse hematopoietic stem cells (HSCs) with the cluster
Aimer
Commentaire
Partagez
